2nd WHO Expert meeting on critically important antimicrobials for human medicine: Categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use, Copenhagen, Denmark, 29–31 May 2007
The 2nd WHO Expert Meeting on Critically Important Antimicrobials for Human Health was held in Copenhagen, Denmark, in May 2007. The meeting was organized to follow up a consultative process on critically important antibacterial agents for human health risk management strategies of non-human use (1st WHO Expert Meeting on Critically Important Antibacterial Agents for Human Medicine, Canberra, February 2005). In this meeting, participants reviewed the two criteria for Critically Important Antimicrobials and re-examined the categorization of all human antibacterial classes in light of new drug development and scientific information since 2005. Participants also prioritized agents within the critically important category in order to allow allocation of resources on the agents for which management of the risks from antimicrobial resistance are needed most urgently.